CVS Group Regulatory News (CVSG)

23 September 2021

CVS Group plc

("CVS", the "Company" or the "Group")

Board Changes

CVS, one of the UK's leading providers of integrated veterinary services, announces that Mike McCollum, Senior Independent Non-Executive Director and Chair of the Audit Committee, has advised the Company that he is stepping down from the Board at the end of his current term to pursue a full-time opportunity outside of the Group. Mike has been a director of the Company for eight and a half years and his service agreement expires on 23 September 2021 coterminous with the release of the Company's 2021 audited results. The Board is pleased to announce that David Wilton will replace Mike and has been appointed as Non-Executive Director with effect from 24 September 2021. David has also agreed to serve as Chair of the Audit Committee. With Mike's departure, Deborah Kemp, who has been a director of the Company for over three and a half years, will take up the role of Senior Independent Non-Executive Director.

David Wilton is a qualified Chartered Accountant with more than 30 years' post qualification experience as a Chief Financial Officer, Non-Executive Director and consultant after many years in corporate finance, primarily in mid cap M&A with Rothschilds. David has held roles in both public and private equity backed companies including as Group Finance Director of WYG plc and as Non-Executive Director and Chair of the Audit Committee of Sweett Group plc. He is currently CFO of Sumo Group plc, the AIM listed provider of acclaimed development, design and publishing services to the video games and entertainment industries.

Richard Connell, Non-executive Chairman of CVS, commented:

"On behalf of the Board, I would like to take this opportunity to thank Mike for his tremendous service over eight and a half years with the Group, including one year as Chair of the Audit Committee and seven as Chair of the Remuneration Committee. We wish him every success in the future.

"I would also like to welcome David to the Board. He joins at an exciting time in the Company's evolution and his skills and experience, particularly in people based businesses, will be welcome in support of the finance function but also more broadly as we capitalise on the growth opportunities before us."

Additional disclosures required under the AIM Rules for Companies:

The following information regarding the appointment of David Charles Wilton, aged 58, is disclosed under Schedule 2(g) of the AIM Rules for Companies:

As at the date of this announcement, David Wilton does not hold any ordinary shares in the Company.

Save as set out above there are no further disclosures pursuant to Rule 17 or Schedule 2(g) of the AIM Rules for Companies in respect of the appointment of David Wilton to the CVS Board.